Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema.
Audren
François
F
Ophthalmology Department, Hôpital Lariboisière, Université Paris 7, Paris, France. francoisaudren@hotmail.com <francoisaudren@hotmail.com>
Tod
Michel
M
Massin
Pascale
P
Benosman
Rym
R
Haouchine
Belkacem
B
Erginay
Ali
A
Caulin
Charles
C
Gaudric
Alain
A
Bergmann
Jean-François
JF
D000328:Adult; D000368:Aged; D003930:Diabetic Retinopathy / Q000188:drug therapy* / Q000378:metabolism; D005938:Glucocorticoids / Q000493:pharmacokinetics* / Q000494:pharmacology*; D006207:Half-Life; D006801:Humans; D007267:Injections; D008266:Macula Lutea / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008269:Macular Edema / Q000188:drug therapy* / Q000378:metabolism; D008875:Middle Aged; D008954:Models, Biological; D013997:Time Factors; D041623:Tomography, Optical Coherence; D014222:Triamcinolone Acetonide / Q000493:pharmacokinetics* / Q000494:pharmacology*; D014822:Vitreous Body
D005938:Glucocorticoids; D014222:Triamcinolone Acetonide